Shares of Spectral Medical Inc. (OTCMKTS:EDTXF – Get Free Report) rose 2.5% during mid-day trading on Wednesday . The company traded as high as $0.61 and last traded at $0.58. Approximately 35,845 shares changed hands during trading, an increase of 147% from the average daily volume of 14,486 shares. The stock had previously closed at $0.57.
Spectral Medical Stock Performance
The firm has a market cap of $165.40 million, a P/E ratio of -8.29 and a beta of 0.54. The company’s 50 day moving average is $0.49 and its 200 day moving average is $0.43.
About Spectral Medical
Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream.
See Also
- Five stocks we like better than Spectral Medical
- What is a Dividend King?
- Viking Therapeutics Stock Pops But Struggles to Hold Gains
- Short Selling – The Pros and Cons
- Qualcomm Stock Just Earned a Fresh Buy Rating—Get Excited
- What is Insider Trading? What You Can Learn from Insider Trading
- Meta Stock Holds Upside Potential as Analysts Cut Price Targets
Receive News & Ratings for Spectral Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectral Medical and related companies with MarketBeat.com's FREE daily email newsletter.
